Showing posts with label infant. Show all posts
Showing posts with label infant. Show all posts

Monday, July 27, 2015

Many new mothers report no physician advice on infant sleep position, breastfeeding

Many new mothers do not receive advice from physicians on aspects of infant care such as sleep position, breastfeeding, immunization and pacifier use, according to a study funded by the National Institutes of Health.
Woman with a sleeping baby
Infants should be placed to sleep alone, on their backs, on a firm sleep surface, such as in a mattress in a safety-approved crib , covered by a fitted sheet. Soft objects, toys, crib bumpers, quilts, comforters and loose bedding should be kept out of the baby’s sleep area.
Health care practitioner groups have issued recommendations and guidelines on all these aspects of infant care, based on research which has found that certain practices can prevent disease and even save lives.
The study authors surveyed a nationally representative sample of more than 1,000 new mothers, inquiring about infant care advice they received from doctors, nurses, family members and the news media.
Roughly 20 percent of mothers said they did not receive advice from their doctors regarding current recommendations on breastfeeding or on placing infants to sleep on their backs — a practice long proven to reduce the risk of sudden infant death syndrome (SIDS). More than 50 percent of mothers reported they received no advice on where their infants should sleep. Room-sharing with parents — but not bed-sharing — is the recommended practice for safe infant sleep.
The study appeared in Pediatrics and was conducted by researchers at Boston Medical Center, Boston University, and Yale University, New Haven, Connecticut.
“Earlier studies have shown that new mothers listen to their physicians,” said Marian Willinger, Ph.D.., of the Pregnancy and Perinatology Branch at NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development, which funded the study. “This survey shows that physicians have an opportunity to provide new mothers with much-needed advice on how to improve infant health and even save infant lives.”
African American women, Hispanic women and first time mothers were more likely to receive advice from their physicians than were white women and mothers of two or more children.
“As a physician, these findings made me stop and really think about how we communicate important information to new parents,” said the study’s first author, Staci R. Eisenberg, M.D., a pediatrician at Boston Medical Center. “We may need to be clearer and more specific in telling new mothers about safe sleep recommendations. From a public health perspective, there is a real opportunity to engage families and the media to promote infant health.”
For the Study of Attitudes and Factors Affecting Infant Care Practices, the researchers enrolled new mothers at delivery from 32 hospitals around the country, with 1031 women eventually taking part in the study. The authors asked the women to complete questionnaires when the infant was between 2 and 6 months of age on advice they received from their infant’s doctor, birth hospital nurses, their family members, and the news media. In addition to finding out whether or not these sources had provided advice on infant care, the questionnaires sought to determine whether the advice was consistent with the recommendations of practitioner groups.
Image of a mother and child sharing a room
Room sharing — keeping the infant’s sleep area in the same room and next to where the caregiver sleeps — is recommended as a way to reduce the risk of SIDS and other sleep-related causes of infant death. Infants should not sleep in an adult bed, on a couch, or on a chair alone, with the parent or caregiver, with siblings or other small children, or with anyone else.
For example, the American Academy of Pediatrics (AAP) recommends that caregivers always place a baby on his or her back for sleep at night and for naps. The women in the study were asked whether they agreed or disagreed with a series of statements on sleep placement: “The nurses at the hospital where my baby was born think that I should place my baby to sleep on the [back, side or stomach.]” If the women agreed with the statement that the baby should be placed to sleep on his or her back, the researchers classified the response as consistent with the AAP recommendation. Agreement with statements on the other placement positions was considered inconsistent with the recommendation.
When it was given, advice from physicians tended to be consistent with recommendations.  However, 10 to 15 percent of the advice given on breastfeeding and pacifier use was not consistent with recommendations, and slightly more than 25 percent was not consistent with recommendations for sleep position or location. Interestingly, of the women who reported physician advice on sleep position that was inconsistent with recommendations, 85 percent reported being advised to place the infant on his or her back and at least one other position—usually the side (which confers increased risk for SIDS relative to back position). In comparison, of the more than 32 percent of mothers reporting family advice regarding infant sleep position that was inconsistent with recommendations, 51 percent had been told to place infants to sleep on their stomach (stomach sleeping has been associated with the greatest increased risk for SIDS).
Physicians and others in a position to offer advice to mothers may fail to do so because they do not know about recommendations or because they disagree with a recommendation, the study authors wrote. Physicians also may be reluctant to give a recommendation they believe is controversial or one that might lead to a lengthy conversation, especially if they are facing time constraints during busy office hours.

Friday, May 29, 2015

Antibiotic approved for treating infant abdominal infections

The antibiotic was approved by the U. S. Food and Drug Administration for treating abdominal infections in children less than 3 months of age. The approval came after a study by a National Institutes of Health research network evaluated the drug in treating children in this age group.
The May 28 issue of The Federal Register described the study which supported the approval of meropenem for “complicated intra-abdominal infections” in children under 3 months of age. Among preterm infants, intestinal perforation or leakage — which is part of complicated intra-abdominal infection — may be life threatening. The study was undertaken under the terms of the Best Pharmaceuticals for Children Act, which directed NIH to conduct studies on drugs used in children but not previously tested in children or in specific pediatric age groups.
Meropenem is a broad spectrum antibiotic — effective against a wide variety of bacteria. The drug has been previously approved to treat complicated intra-abdominal infections and complicated skin infections in adults and older children, and for treating children 3 months of age and older with bacterial meningitis — an infection of the fluid bathing the brain and spinal cord. During the last several years, physicians have begun prescribing meropenem for preterm infants with serious abdominal infections. Because they lacked an effective alternative, many physicians had prescribed the drug for a use other than what the FDA had approved. The NIH study was undertaken in response to a written request from the FDA to evaluate the dosing and safety of meropenem in the treatment of complicated intra-abdominal infections in infants under 3 months of age.
“This study shows that meropenem is appropriate for treating complicated intra-abdominal infections in very young infants. In addition, we now have dosing guidelines for various age groups of premature infants,” said Anne Zajicek, M.D., Pharm.D., chief of the Obstetric and Pediatric Pharmacology and Therapeutics Branch at NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which funded the study.
Dr. Zajicek explained that physicians often need to extrapolate from studies of adults when prescribing for pediatric patients, because many drugs have never been tested specifically for use in children. However, because of their smaller size, differences in metabolism, and other physical differences from adults, many drugs may affect children differently than they do adults. Under the Best Pharmaceuticals for Children Act, NICHD works with FDA to identify drugs not tested in children to determine if they are appropriate for use in children.
The NICHD commissioned the study to investigate meropenem use in 200 infants under 3 months of age, including premature infants. Researchers examined how the drug was absorbed and distributed throughout the body, and used that information to develop dosing recommendations for different age groups of infants, including premature infants of different ages. In addition, the study evaluated side effects. Based on this study, treatment of infants with meropenem was safe and was not associated with increased risk for serious side effects.

Saturday, July 12, 2014

Canada: Walmart Recalls Enfamil A+ Infant Formula

The Canadian Food Inspection Agency (CFIA), Walmart Canada Corporation and Mead Johnson Nutrition (Canada) Company are advising the public that some bottles of Enfamil A+ Ready-to-Feed Infant Formula have been found with the tamper-proof seal broken and blue tape applied in its place. These bottles were found to contain water and some formula residue instead of infant formula.
A total of three complaints have been reported in Brampton and Mississauga.
Walmart immediately removed the product from sale in a number of stores in the Halton and Peel regions of Toronto and did not find any additional product that had been altered.

Products

Brand NameCommon NameSizeCodes(s) on ProductUPC
Enfamil A+Ready to Feed Infant Formula18 bottles x 237 mLVarious0 56796 90518 0

What You Should Do

Consumers using infant formulas should examine the containers to ensure that the security seal is intact and has not been altered. If you have product that appears to have been altered, do not use or consume it. Product that appears to have been altered should be thrown out or returned to the store where it was purchased.

Monday, December 16, 2013

12/15/13 Health News: Raw Milk illness Under Reported, Antibiotics in Animal Feed, Infant Formula in Korea

MN STUDY: RAW MILK ILLNESSES GREATLY UNDER REPORTED
Despite the somewhat commonplace occurrence of illness outbreaks associated with unpasteurized milk, the number of illnesses linked to drinking raw milk is much higher than those counted in outbreak reports, according to an analysis published by the Minnesota Department of Health on Wednesday. Looking at 10 years of health department data between 2001 and 2010,... Continue Reading

SEOUL DAIRY IS ALL ABOUT KEEPING TRUST OF SOUTH KOREAN MOTHERS
Because so many Asian consumers look to them for food safety cues, the influence of South Korean mothers is hard to overestimate. Just ask Wan Sik Kim, managing director of the food safety center at Seoul-based Maeil Dairies. He’ll tell you that no force in the country, not government regulators nor the competition, has more... Continue Reading

WILL FDA’S VOLUNTARY PLAN ACTUALLY REDUCE ANTIBIOTICS IN ANIMAL FEED?

U.S. Food and Drug Administration has released the final version of a voluntary plan to phase out the use of certain antibiotics in food animals. Antibiotics are added to the feed or drinking water of cattle, hogs, poultry and other food-producing animals to help them gain weight faster or use less food to gain... Continue Reading

Monday, October 14, 2013

Aluminum Found in Infant Formula

In an article published in BMC Pediatrics, researchers from Keele University in Staffordshire, U.K. pointed out that their recent research published in this journal highlighted the issue of the high content of aluminium in infant formulas. The expectation was that the findings would serve as a catalyst for manufacturers to address this significant problem. It is critically important that parents and other users have confidence in the safety of infant formulas and that they have reliable information to use in choosing a product with a lower content of aluminium. Herein, we have significantly extended the scope of the previous research and the aluminium content of 30 of the most widely available and often used infant formulas has been measured.
Both ready-to-drink milks and milk powders were contaminated with aluminium. The concentration of aluminium across all milk products ranged from ca 100 to 430 μg/L. The concentration of aluminium in two soy-based milk products was 656 and 756 μg/L. The intake of aluminium from non-soy-based infant formulas varied from ca 100 to 300 μg per day. For soya-based milks it could be as high as 700 μg per day.
All 30 infant formulas were contaminated with aluminium. There was no clear evidence that that contamination had been addressed and reduced. It is the opinion of the authors of this study that regulatory and other non-voluntary methods are now required to reduce the aluminium content of infant formulas and thereby protect infants from chronic exposure to dietary aluminium.
In its Public Health Statement for Aluminum, the U.S. Centers for Disease Control and Prevention state:
  • An average adult in the United States consumes about 7-9 mg of aluminum per day in food.
  • The concentration of aluminum in natural waters (e.g., ponds, lakes, streams) is generally below 0.1 milligrams per liter (mg/L).
  • People generally consume little aluminum from drinking water. Water is sometimes treated with aluminum salts while it is processed to become drinking water. But, even then, aluminum levels generally do not exceed 0.1 mg/L. Several cities have reported concentrations as high as 0.4–1 mg/L of aluminum in their drinking water.
  • Oral exposure to aluminum is usually not harmful. Some studies show that people exposed to high levels of aluminum may develop Alzheimer’s disease, but other studies have not found this to be true. We do not know for certain that aluminum causes Alzheimer’s disease.
  • Some people who have kidney disease store a lot of aluminum in their bodies. The kidney disease causes less aluminum to be removed from the body in urine. Sometimes such people developed bone or brain diseases that doctors suspect were caused by the excess aluminum.
  • Although over-the-counter oral products containing aluminum are considered safe in healthy individuals at recommended doses, adverse effects have been observed following long-term use in some individuals.
  • Brain and bone disease caused by high levels of aluminum in the body have been seen in children with kidney disease. Bone disease has also been seen in children taking some medicines containing aluminum. In these children, the bone damage is caused by aluminum in the stomach preventing the absorption of phosphate, a chemical compound required for healthy bones.
  • Aluminum is found in breast milk, but only a small amount of this aluminum will enter the infant’s body through breastfeeding. Typical aluminum concentrations in human breast milk range from 0.0092 to 0.049 mg/L. Aluminum is also found in soy-based infant formula (0.46–0.93 mg/L) and milk-based infant formula (0.058–0.15 mg/L).
  • We do not know if aluminum will cause birth defects in people. Birth defects have not been seen in animals.
  • Very young animals appeared weaker and less active in their cages and some movements appeared less coordinated when their mothers were exposed to large amounts of aluminum during pregnancy and while nursing. In addition, aluminum also affected the animal’s memory. These effects are similar to those that have been seen in adults.
  • It does not appear that children are more sensitive to aluminum than adult animals are.

Monday, October 7, 2013

Recall: 3 Batches of Motrin Infants' Drops Contaminated

MOTRIN infants' drops




McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. (“McNeil”) is voluntarily recalling at the retail level three lots, approximately 200,000 bottles, of Concentrated MOTRIN® Infants’ Drops Original Berry Flavor 1/2 fl oz bottles distributed in the United States. . McNeil is asking retailers to remove the affected lots from store shelves, and is asking consumers to stop using and dispose of any product they may have that is included in this recall.








FULL RECALLED PRODUCT LIST:
Product
Lot #
UPC Code
Case UPC Code
Concentrated MOTRIN® Infants’ Drops
Original Berry Flavor 1/2 fl oz bottles


NDC 50580-100-18
DCB3T01
300450524157
30300450524158

DDB4R01



DDB4S01




After releasing these three lots of Concentrated MOTRIN® Infants’ Drops Original Berry Flavor 1/2 fl oz into the market, tiny plastic particles ( about the size of a poppy seed) were identified in a different product lot during manufacturing. This lot was not released to the market. It was determined that the particles originated in a shipment from a third party supplier of ibuprofen.
Original Berry Flavor 1/2 fl oz. Out of an abundance of caution, McNeil is voluntarily recalling the three lots released to the market made with the same batch of active ingredient. McNeil has worked with the third party to ensure that corrective measures are currently in place and are effective. The potential for adverse medical events related to the reason for this recall is not likely. Concentrated Infants’ MOTRIN® Drops Dye-Free Berry Flavor 1 fl oz is not included in this recall. Children’s or Adult MOTRIN® products are not included in this recall.

Monday, August 5, 2013

Vietnam: Recall Similac Infant Formula

Vietnamese health authorities have ordered the recall of a New Zealand-made infant formula after that country issued a global warning that it might contain bacteria that can cause the deadly botulism.
The Food Safety Department Saturday ordered Abbott Vietnam to stop distributing Similac Gain Plus Eye-Q for children between one and three years old, There were 10 lots that were imported between June 17 and July 3. They were removed from grocery shelves.

Earlier the department received a warning that whey protein concentrate, the cheapest and most common form of whey protein, produced by New Zealand-based Fonterra could be contaminated with clostridium botulinum.

The Vietnamese agency also warned about Karicare formula products made by New Zealand's Nutricia company using Fonterra’s whey concentrate.The New Zealand’s Ministry of Science and Innovation said the risky Karicare products have only been sold locally,The Vietnamese Food Safety Department nevertheless ordered Chau Uc Nutrition which imports Karicare products to report a list of its purchases by August 6 to make sure,

An Abbott Vietnam spokesperson said the company has informed customers about the risky lots and told them they can exchange any product they may have bought. Customers can call its hotline at 19001519 for any questions or complaints, the spokesperson said.

Tran Quang Trung, head of the Food Safety Department, said since the tainted lots were only imported recently, not many cans have been sold yet.
Samples from the cans would be tested this week, he said.